Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment
Clinical trial NCT03536780 · UNKNOWN
Trial details
- NCT number
- NCT03536780
- Sponsor
- Gachon University Gil Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2021-12-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.